Sale!
Replica Osimertinib: Targeted Third-Gen EGFR-TKI NSCLC Treatment
Replica Osimertinib: Targeted Third-Gen EGFR-TKI NSCLC Treatment - Image 2

Replica Osimertinib: Targeted Third-Gen EGFR-TKI NSCLC Treatment

Original price was: $757.00.Current price is: $598.00.

Treats EGFR-mutated non-small cell lung cancer, Third-generation irreversible EGFR-TKI, Targets EGFR Ex19Del and EGFR L858R mutations, Cerebral metastasis activity, Orally administered,

SKU: SKU67EFR2OYC Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Treats EGFR-mutated non-small cell lung cancer, Third-generation irreversible EGFR-TKI, Targets EGFR Ex19Del and EGFR L858R mutations, Cerebral metastasis activity, Orally administered,

Related products

Scroll to Top